This is pretty neat. This is not a pure diabetes news – but it has a strong impact. Yesterday, the FDA approved the first ever cell-based gene therapy treatment in the US, in this case for a form of juvenile leukemia (acute lymphoblastic leukemia, in children and young adults up to 25):
“The FDA approved Kymriah, which scientists refer to as a “living drug” because it involves using genetically modified immune cells from patients to attack their cancer. […] The treatment involves removing immune system cells known as T cells from each patient and genetically modifying the cells in the laboratory to attack and kill leukemia cells. The genetically modified cells are then infused back into patients. It’s also known as CAR-T cell therapy.”
The reason while I think this is pretty cool: this time, the application is not diabetes – but an upcoming one could be: genetically modified immune cell therapy is now a weapon against design. Pretty darn great!
I feel like I am living in my own future
On second thought, I now realize that we all are, from the second after we were born and on.